Literature DB >> 2673980

Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis.

T Ishihara1, T Nagasawa, T Yokota, T Gondo, M Takahashi, F Uchino.   

Abstract

The cerebrum, cerebellum, and choroid plexuses from 16 patients with systemic amyloidosis, and the pituitary glands from 14 of these patients, were investigated histologically and immunohistochemically. Cerebrovascular amyloid (CVA) was found in the leptomeninges and cortices of six patients with systemic amyloidosis, including two patients with amyloid A protein (AA) amyloidosis related to serum amyloid A protein, one with AL amyloidosis related to immunoglobulin light chain (AL), two with familial type I amyloidotic polyneuropathy (FAP), and one with senile systemic amyloidosis (SSA). CVA protein from two patients with FAP reacted with anti-human prealbumin antibody similar to that of the visceral organs of these two patients. CVA in SSA reacted with anti-human prealbumin antibody and anti-beta protein antibody. Vascular amyloid was frequently noted in the pituitary glands and choroid plexuses of patients with systemic amyloidosis, and was found to be identical to that in the visceral organs (heart, kidney, and intestine) of these patients. CVA in the leptomeninges and cortices from two patients with AA amyloidosis and one with AL amyloidosis reacted with anti-beta protein monoclonal antibody but not with anti-human AA monoclonal antibody, anti-human A lambda antisera, and anti-human A kappa antisera. We suggest that amyloid proteins of AA and AL amyloidosis do not readily accumulate in the vessels in the leptomeninges and cortices even though the proteins circulate, and that beta protein is not derived from a serum precursor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673980     DOI: 10.1016/0046-8177(89)90102-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.

Authors:  H V Vinters; G S Nishimura; D L Secor; W M Pardridge
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord.

Authors:  Mika Kitajima; Yukunori Korogi; Masayuki Yamura; Ichiro Ikushima; Yoshiko Hayashida; Yukio Ando; Makoto Uchino; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy.

Authors:  M Ushiyama; S Ikeda; N Yanagisawa
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Clinical Neuropathology image 3-2017: CNS involvement in systemic amyloidosis restricted to the choroid plexus.

Authors:  Ellen Gelpi; Martin Susani; Robert Wiebringhaus; Andreas Aschauer; Andreas Kammerlander; Mirjam I Lutz; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2017 May/Jun       Impact factor: 1.368

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.